PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 19 filers reported holding PTC THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $25,518,000 | +69.3% | 25,417,000 | +75.0% | 0.53% | +56.1% |
| Q1 2022 | $15,076,000 | -1.6% | 14,527,000 | 0.0% | 0.34% | +5.0% |
| Q4 2021 | $15,326,000 | +1.8% | 14,527,000 | 0.0% | 0.32% | +9.2% |
| Q3 2021 | $15,061,000 | -3.2% | 14,527,000 | 0.0% | 0.29% | +6.5% |
| Q2 2021 | $15,558,000 | -6.8% | 14,527,000 | 0.0% | 0.28% | -21.4% |
| Q1 2021 | $16,688,000 | -10.2% | 14,527,000 | 0.0% | 0.35% | -4.4% |
| Q4 2020 | $18,577,000 | +12.8% | 14,527,000 | 0.0% | 0.37% | -8.5% |
| Q3 2020 | $16,476,000 | -43.0% | 14,527,000 | -41.6% | 0.40% | -52.4% |
| Q2 2020 | $28,921,000 | +7.7% | 24,877,000 | 0.0% | 0.84% | -1.2% |
| Q1 2020 | $26,850,000 | -5.5% | 24,877,000 | 0.0% | 0.85% | -6.0% |
| Q4 2019 | $28,400,000 | +9.6% | 24,877,000 | 0.0% | 0.91% | -14.2% |
| Q3 2019 | $25,902,000 | -6.0% | 24,877,000 | 0.0% | 1.06% | +6.7% |
| Q2 2019 | $27,557,000 | – | 24,877,000 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |